ARCHIVES

After a “humble” start at NCI, von Eschenbach set unachievable goal.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

HHS Back down, Says Now It Will Support Survey Of Research Facilities

October 28, 1983

Senate committee approves Lester Crawford’s nomination for FDA Commissioner.

June 17, 2005

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990